Form 8-K - Current report:
SEC Accession No. 0001104659-25-029974
Filing Date
2025-03-31
Accepted
2025-03-31 17:12:23
Documents
15
Period of Report
2025-03-31
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2510844d1_8k.htm   iXBRL 8-K 25503
2 EXHIBIT 99.1 tm2510844d1_ex99-1.htm EX-99.1 323957
6 GRAPHIC tm2510844d1_ex99-1img011.jpg GRAPHIC 47689
  Complete submission text file 0001104659-25-029974.txt   614776

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA ctso-20250331.xsd EX-101.SCH 3026
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE ctso-20250331_lab.xml EX-101.LAB 34239
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE ctso-20250331_pre.xml EX-101.PRE 22366
17 EXTRACTED XBRL INSTANCE DOCUMENT tm2510844d1_8k_htm.xml XML 3565
Mailing Address 305 COLLEGE ROAD EAST PRINCETON NJ 08540
Business Address 305 COLLEGE ROAD EAST PRINCETON NJ 08540 973-329-8885
Cytosorbents Corp (Filer) CIK: 0001175151 (see all company filings)

EIN.: 980373793 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36792 | Film No.: 25794901
SIC: 3841 Surgical & Medical Instruments & Apparatus
(CF Office: 08 Industrial Applications and Services)